<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Wipe_Out_CAPNS1_Issues_For_Good</id>
		<title>Wipe Out CAPNS1 Issues For Good - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Wipe_Out_CAPNS1_Issues_For_Good"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Wipe_Out_CAPNS1_Issues_For_Good&amp;action=history"/>
		<updated>2026-05-04T19:55:40Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Wipe_Out_CAPNS1_Issues_For_Good&amp;diff=174483&amp;oldid=prev</id>
		<title>Bumper0hook: Створена сторінка: The aim of this study is to compare [http://www.selleckchem.com/products/bmn-673.html Talazoparib manufacturer] the efficacy of endoscopically applied hemostati...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Wipe_Out_CAPNS1_Issues_For_Good&amp;diff=174483&amp;oldid=prev"/>
				<updated>2017-05-08T18:04:35Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: The aim of this study is to compare [http://www.selleckchem.com/products/bmn-673.html Talazoparib manufacturer] the efficacy of endoscopically applied hemostati...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;The aim of this study is to compare [http://www.selleckchem.com/products/bmn-673.html Talazoparib manufacturer] the efficacy of endoscopically applied hemostatic techniques that maintain vascular flow in an animal model of carotid artery injury. A total of 20 sheep underwent ICA dissection/isolation followed by the placement of the artery within a modified ��sinus model otorhino neuro trainer�� (SIMONT) model. A standardized 4-mm carotid artery injury was created endoscopically. Randomization of sheep to receive 1 of 5 hemostatic techniques was performed (Floseal, oxidized regenerated cellulose, Chitosan gel, muscle patch, or the U-Clip anastomotic device). Specific outcome measures were time to hemostasis, duration of time mean arterial pressure (MAP) was &amp;gt;55 mmHg, blood loss, and survival time. Muscle patch hemostasis and the U-Clip anastomotic device were significantly more effective at achieving primary hemostasis rapidly, reducing total blood loss, and increasing survival time and time MAP was &amp;gt;55 mmHg more than Floseal, oxidized regenerated cellulose, and Chitosan gel (p [https://en.wikipedia.org/wiki/CAPNS1 CAPNS1] Floseal and oxidized regenerated cellulose failed to achieve hemostasis in any animal, with all animals exsanguinating prematurely. In the sheep model of endoscopic ICA injury, the muscle patch and U-Clip anastomotic device significantly improved survival, reduced blood loss, and achieved primary hemostasis while maintaining vascular patency. ? 2011 ARS-AAOA, LLC. &amp;quot;&amp;quot;The purpose of this study was to survey program directors of the accredited otolaryngology residency programs and resident attendees of the 2013 American Academy of Otolaryngic Allergy (AAOA) Basic/MOC Course regarding resident education and participation as well as assessment of competency in otolaryngic allergy and immunotherapy. A multiple-choice questionnaire was sent to all accredited otolaryngology residency training programs in the United States as part of resident attendance at the 2013 [http://www.selleckchem.com/products/s-gsk1349572.html selleck] AAOA CORE Basic/MOC Course. Following this, a similar multiple-choice survey was sent to all resident attendees from the programs that responded positively. Program directors reported that 73% of their academic institutions offer allergy testing and immunotherapy. More PDs than residents indicated that residents participate in allergy practice and perform/interpret skin testing and in vitro testing, and more residents (85%) than program directors (63%) reported inadequate or no allergy training. Program directors and residents equally indicated that residents do not calculate immunotherapy vial formulations or administer immunotherapy injections.&lt;/div&gt;</summary>
		<author><name>Bumper0hook</name></author>	</entry>

	</feed>